Variation in protection by BCG: implications of and for heterologous immunity
Lancet
.
1995 Nov 18;346(8986):1339-45.
doi: 10.1016/s0140-6736(95)92348-9.
Author
P E Fine
1
Affiliation
1
Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, UK.
PMID:
7475776
DOI:
10.1016/s0140-6736(95)92348-9
No abstract available
Publication types
Review
MeSH terms
Animals
BCG Vaccine*
Environmental Exposure
Humans
Mycobacterium Infections / epidemiology
Mycobacterium Infections / immunology
Mycobacterium Infections / prevention & control*
Prevalence
Treatment Outcome
Substances
BCG Vaccine